AMAL ABDULKADIR: Open Payments
NPI 1396937751 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 15 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $213 |
| ABBVIE INC. | 3 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $67 |
| Lundbeck LLC | 4 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
Products named: Auvelity, VRAYLAR, CAPLYTA, REXULTI, SPRAVATO.
Industry payments across CA — which companies pay providers there.
